Patient preferences regarding recontact by cancer genetics clinicians

Constance A. Griffin, Jennifer E. Axilbund, Ann Marie Codori, Ginny Deise, Betty May, Cheryl Pendergrass, Miriam Tillery, Jill Brensinger Trimbath, Francis M Giardiello

Research output: Contribution to journalArticle

Abstract

Background: Ongoing advances in cancer genetics lead to new opportunities for early disease detection, predictive genetic testing and potential interventions. Limited information exists on patient preferences concerning recontact to provide updated information. We evaluated colon cancer genetics patient preferences concerning recontact about advances in medical genetics. Methods: Information was mailed to 851 individuals seen at the Colon Cancer Risk Assessment Clinic at the Johns Hopkins Hospital and to participants in a colon cancer gene testing study seen during an 8-year period. Information provided included description of advances in gene testing technology, discovery of MSH6 and MYH genes, detailed fact sheets and a survey of patient preferences for notification and potential uses of new information. Results: Most patients wanted an ongoing relationship with genetics providers (63%), reinitiated by genetics providers (65%) and contact only with information specifically relevant to them (51%). Most preferred personalized letters as the means of contact (55%). Reasons for and against recontact and circumstances in which individuals would pursue additional genetic testing were also tabulated. There were few statistically significant differences in the responses between clinic and study participants. Conclusion: Patients evaluated in a colon cancer risk assessment clinic want updated information at a rate similar to those who participated in a colon cancer gene testing study. These findings have implications for the consultative nonlongitudinal nature of such clinics and suggest patient preferences for personally-tailored information could be labor intensive.

Original languageEnglish (US)
Pages (from-to)265-273
Number of pages9
JournalFamilial Cancer
Volume6
Issue number3
DOIs
StatePublished - Sep 2007

Fingerprint

Duty to Recontact
Patient Preference
Colonic Neoplasms
Neoplasm Genes
Genetic Testing
Neoplasms
Medical Genetics
Genes
Early Diagnosis
Technology

Keywords

  • Cancer genetics
  • Colon cancer
  • Genetic testing
  • Recontact

ASJC Scopus subject areas

  • Cancer Research
  • Genetics

Cite this

Griffin, C. A., Axilbund, J. E., Codori, A. M., Deise, G., May, B., Pendergrass, C., ... Giardiello, F. M. (2007). Patient preferences regarding recontact by cancer genetics clinicians. Familial Cancer, 6(3), 265-273. https://doi.org/10.1007/s10689-007-9117-0

Patient preferences regarding recontact by cancer genetics clinicians. / Griffin, Constance A.; Axilbund, Jennifer E.; Codori, Ann Marie; Deise, Ginny; May, Betty; Pendergrass, Cheryl; Tillery, Miriam; Brensinger Trimbath, Jill; Giardiello, Francis M.

In: Familial Cancer, Vol. 6, No. 3, 09.2007, p. 265-273.

Research output: Contribution to journalArticle

Griffin, CA, Axilbund, JE, Codori, AM, Deise, G, May, B, Pendergrass, C, Tillery, M, Brensinger Trimbath, J & Giardiello, FM 2007, 'Patient preferences regarding recontact by cancer genetics clinicians', Familial Cancer, vol. 6, no. 3, pp. 265-273. https://doi.org/10.1007/s10689-007-9117-0
Griffin CA, Axilbund JE, Codori AM, Deise G, May B, Pendergrass C et al. Patient preferences regarding recontact by cancer genetics clinicians. Familial Cancer. 2007 Sep;6(3):265-273. https://doi.org/10.1007/s10689-007-9117-0
Griffin, Constance A. ; Axilbund, Jennifer E. ; Codori, Ann Marie ; Deise, Ginny ; May, Betty ; Pendergrass, Cheryl ; Tillery, Miriam ; Brensinger Trimbath, Jill ; Giardiello, Francis M. / Patient preferences regarding recontact by cancer genetics clinicians. In: Familial Cancer. 2007 ; Vol. 6, No. 3. pp. 265-273.
@article{5bfe34075f7b43aa8f646cb777ca9c63,
title = "Patient preferences regarding recontact by cancer genetics clinicians",
abstract = "Background: Ongoing advances in cancer genetics lead to new opportunities for early disease detection, predictive genetic testing and potential interventions. Limited information exists on patient preferences concerning recontact to provide updated information. We evaluated colon cancer genetics patient preferences concerning recontact about advances in medical genetics. Methods: Information was mailed to 851 individuals seen at the Colon Cancer Risk Assessment Clinic at the Johns Hopkins Hospital and to participants in a colon cancer gene testing study seen during an 8-year period. Information provided included description of advances in gene testing technology, discovery of MSH6 and MYH genes, detailed fact sheets and a survey of patient preferences for notification and potential uses of new information. Results: Most patients wanted an ongoing relationship with genetics providers (63{\%}), reinitiated by genetics providers (65{\%}) and contact only with information specifically relevant to them (51{\%}). Most preferred personalized letters as the means of contact (55{\%}). Reasons for and against recontact and circumstances in which individuals would pursue additional genetic testing were also tabulated. There were few statistically significant differences in the responses between clinic and study participants. Conclusion: Patients evaluated in a colon cancer risk assessment clinic want updated information at a rate similar to those who participated in a colon cancer gene testing study. These findings have implications for the consultative nonlongitudinal nature of such clinics and suggest patient preferences for personally-tailored information could be labor intensive.",
keywords = "Cancer genetics, Colon cancer, Genetic testing, Recontact",
author = "Griffin, {Constance A.} and Axilbund, {Jennifer E.} and Codori, {Ann Marie} and Ginny Deise and Betty May and Cheryl Pendergrass and Miriam Tillery and {Brensinger Trimbath}, Jill and Giardiello, {Francis M}",
year = "2007",
month = "9",
doi = "10.1007/s10689-007-9117-0",
language = "English (US)",
volume = "6",
pages = "265--273",
journal = "Familial Cancer",
issn = "1389-9600",
publisher = "Springer Netherlands",
number = "3",

}

TY - JOUR

T1 - Patient preferences regarding recontact by cancer genetics clinicians

AU - Griffin, Constance A.

AU - Axilbund, Jennifer E.

AU - Codori, Ann Marie

AU - Deise, Ginny

AU - May, Betty

AU - Pendergrass, Cheryl

AU - Tillery, Miriam

AU - Brensinger Trimbath, Jill

AU - Giardiello, Francis M

PY - 2007/9

Y1 - 2007/9

N2 - Background: Ongoing advances in cancer genetics lead to new opportunities for early disease detection, predictive genetic testing and potential interventions. Limited information exists on patient preferences concerning recontact to provide updated information. We evaluated colon cancer genetics patient preferences concerning recontact about advances in medical genetics. Methods: Information was mailed to 851 individuals seen at the Colon Cancer Risk Assessment Clinic at the Johns Hopkins Hospital and to participants in a colon cancer gene testing study seen during an 8-year period. Information provided included description of advances in gene testing technology, discovery of MSH6 and MYH genes, detailed fact sheets and a survey of patient preferences for notification and potential uses of new information. Results: Most patients wanted an ongoing relationship with genetics providers (63%), reinitiated by genetics providers (65%) and contact only with information specifically relevant to them (51%). Most preferred personalized letters as the means of contact (55%). Reasons for and against recontact and circumstances in which individuals would pursue additional genetic testing were also tabulated. There were few statistically significant differences in the responses between clinic and study participants. Conclusion: Patients evaluated in a colon cancer risk assessment clinic want updated information at a rate similar to those who participated in a colon cancer gene testing study. These findings have implications for the consultative nonlongitudinal nature of such clinics and suggest patient preferences for personally-tailored information could be labor intensive.

AB - Background: Ongoing advances in cancer genetics lead to new opportunities for early disease detection, predictive genetic testing and potential interventions. Limited information exists on patient preferences concerning recontact to provide updated information. We evaluated colon cancer genetics patient preferences concerning recontact about advances in medical genetics. Methods: Information was mailed to 851 individuals seen at the Colon Cancer Risk Assessment Clinic at the Johns Hopkins Hospital and to participants in a colon cancer gene testing study seen during an 8-year period. Information provided included description of advances in gene testing technology, discovery of MSH6 and MYH genes, detailed fact sheets and a survey of patient preferences for notification and potential uses of new information. Results: Most patients wanted an ongoing relationship with genetics providers (63%), reinitiated by genetics providers (65%) and contact only with information specifically relevant to them (51%). Most preferred personalized letters as the means of contact (55%). Reasons for and against recontact and circumstances in which individuals would pursue additional genetic testing were also tabulated. There were few statistically significant differences in the responses between clinic and study participants. Conclusion: Patients evaluated in a colon cancer risk assessment clinic want updated information at a rate similar to those who participated in a colon cancer gene testing study. These findings have implications for the consultative nonlongitudinal nature of such clinics and suggest patient preferences for personally-tailored information could be labor intensive.

KW - Cancer genetics

KW - Colon cancer

KW - Genetic testing

KW - Recontact

UR - http://www.scopus.com/inward/record.url?scp=34547395827&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547395827&partnerID=8YFLogxK

U2 - 10.1007/s10689-007-9117-0

DO - 10.1007/s10689-007-9117-0

M3 - Article

VL - 6

SP - 265

EP - 273

JO - Familial Cancer

JF - Familial Cancer

SN - 1389-9600

IS - 3

ER -